Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label amiloride extension after prior antihypertensive crossover study
2007-005655-42Phase 4Completed
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of amiloride in essential hypertension, sponsored by Cambridge University Hospitals NHS Foundation Trust. Primary endpoint: Metabolic detection by oral glucose tolerance test. Started Mar 2008; status: completed.
02
Drugs
amiloride
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2007-005655-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005655-42.